The QualityStocks Daily Wednesday, August 18th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(VRPX) $22.9000 +49.19%

MarketClub Analysis(MDJH) $5.9600 +27.62%

NetworkNewsWire(SLI) $7.1600 +22.60%

The QualityStocks Daily Stock List

Abeona Therapeutics (ABEO)

MarketBeat, MarketClub Analysis, TraderPower, StockMarketWatch, InvestorPlace, Streetwise Reports, StreetInsider, PCG Advisory, BUYINS.NET, Kiplinger Today, Money Morning, Barchart, SmallCap Network, Investopedia, Marketbeat.com, QualityStocks, Zacks, Stock Beast, Money Map Press, Stock News Now, StockOodles, Street Insider, TopPennyStockMovers, Traders For Cash Flow, Trades Of The Day, Equities.com, Daily Trade Alert, Wall Street Mover and Short Term Wealth reported earlier on Abeona Therapeutics (ABEO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Abeona Therapeutics Inc. (NASDAQ: ABEO) (FRA: PCJP) is a clinical-stage biopharmaceutical firm that is focused on the development of cell and gene therapies for fatal rare genetic illnesses.

The firm has its headquarters in New York and was incorporated in 1974. Prior to its name change in June 2015, the firm was known as PlasmaTech Biopharmaceuticals Inc. It operates as part of the pharmaceutical manufacturing industry, under the health care sector, in the biotech and pharma sub-industry.

The company utilizes its multi-platform expertise in the manufacture, delivery, development and discovery of new cell and gene therapies. Its fully operational manufacturing facility produces vectors and therapies for clinical and pre-clinical studies.

The enterprise’s pipeline is made up of a formulation dubbed ABO-5OX, which has been developed to treat genetic eye disorders; a formulation known as ABO-401, which is indicated for the treatment of cystic fibrosis and ABO-201, which has been developed to treat CLN3 disease. It also develops an AAV-based gene therapy dubbed ABO-101, indicated for the treatment of the Sanfilippo syndrome type B; an adeno-associated gene therapy which is virus-based known as ABO-102, which was developed to treat the Sanfilippo syndrome type A; and a gene-corrected autologous cell therapy dubbed EB-101, developed for recessive dystrophic epidermolysis bullosa.

The company’s ABO-102 formulation may soon be approved by the FDA following a successful meeting on its pivotal trial to support its approval. The treatment’s success will not only benefit patients with Sanfilippo syndrome type A but also encourage more investments into the firm, which will have a positive effect on its growth.

Abeona Therapeutics (ABEO), closed Wednesday's trading session at $1.23, up 5.1282%, on 499,650 volume with 2,350 trades. The average volume for the last 3 months is 1.355M and the stock's 52-week low/high is $0.989499986/$3.78990006.

Aditxt (ADTX)

BUYINS.NET, QualityStocks, StreetInsider, StockOnion, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, Penny Pick Finders, PCG Advisory, OTCtipReporter, MarketClub Analysis, MarketBeat, HotOTC and Buzz Stocks reported earlier on Aditxt (ADTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aditxt Inc. (NASDAQ: ADTX) is biotechnology firm that is engaged in the development of technologies which are focused on improving the immune system’s health by immune monitoring and reprogramming.

The firm has its headquarters in Richmond, Virginia and was incorporated in 2019, on September 28th by Amro Albanna, Shahrokh Shabahang and Leonard L. Bailey. Prior to its name change in July 2021, the firm was known as ADiTx Therapeutics Inc.

The company is party to a license agreement with Leland Standford Junior University and Loma Linda University. It operates as part the pharmaceutical and medicine manufacturing industry, under the health care sector, in the biotech and pharma sub-industry and serves consumers across the globe.

The enterprise is involved in the development of a new nucleic acid-based technology dubbed Apoptotic DNA Immunotherapy, which uses an approach that mimics the way an individual’s body naturally induces tolerance to its tissues. It is also engaged in the development of AditxtScore, which enables people to monitor, manage and understand their immune profiles so that they can be informed about attacks by or on their immune systems. In addition to this, the enterprise also develops ADi products for allergies, autoimmune diseases and for the transplantation of organs, like skin grafting. Furthermore, it has developed AditxtScore for Covid-19, which tracks multiple combinations of antibodies and neutralizes antibody responses.

The firm recently entered into a partnership with Great Lakes Medical Laboratory Inc. to provide its AditxtScore for Covid-19 in Michigan. This move will boost its sales as well as extend the firm’s consumer reach, which will bring in more investments into the firm.

Aditxt (ADTX), closed Wednesday's trading session at $1.96, up 8.8889%, on 217,943 volume with 755 trades. The average volume for the last 3 months is 216,004 and the stock's 52-week low/high is $1.62/$6.73000001.

Aesthetic Medical International Holdings Group (AIH)

StreetInsider, MarketClub Analysis, MarketBeat and BUYINS.NET reported earlier on Aesthetic Medical International Holdings Group (AIH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) (FRA: 3FMA) is a holding firm that is engaged in the provision of aesthetic medical services, via its hospitals.

The firm has its headquarters in Shenzhen, the People’s Republic of China and was incorporated in 1997, by Ding Wen Ting and Zhou Peng Wu. It serves consumers in China.

The company operates 28 treatment centers in Singapore, Hong Kong and China. Its hospitals include the Chongqing Pengai hospital, Pengcheng Hospital and the Shenzhen Pengai Hospital. The company generates its revenue from 3 service offerings namely general healthcare services and other aesthetic medical services, surgical aesthetic medical services and non-surgical aesthetic medical services, which comprises of energy based and minimally invasive aesthetic treatments. The majority of the firm’s revenue is derived from the non-surgical aesthetic medical service offering and comes from China. It primarily operates its businesses in the domestic market.

The enterprise offers one-stop aesthetic service offerings which include non-surgical aesthetic treatments that are made up of energy-based treatments like ultraviolet light, ultrasound and laser treatments, and minimally invasive treatments, surgical aesthetic treatments like liposuction, breast augmentation, rhinoplasty and eye surgery, and other aesthetic services like cosmetic dentistry. In addition to this, the enterprise also offers general healthcare and other medical services which include obstetrics, gynecology, urology and internal medicine treatment services, as well as hair loss, dermatology and dentistry treatment services.

The company is committed to further expanding its non-surgical aesthetic medical services across various regions in China. This move will extend the company’s consumer reach and encourage more investments into the firm, which will in turn boost the company’s growth.

Aesthetic Medical International Holdings Group (AIH), closed Wednesday's trading session at $4.22, off by 0.705882%, on 37,612 volume with 191 trades. The average volume for the last 3 months is 258,675 and the stock's 52-week low/high is $3.80999994/$11.2399997.

Alternet Systems (ALYI)

QualityStocks, TJ PennyChase, Tip.us, StocksToBuyNow, Wall Street Corner, Alternet Systems, SeriousTraders, PennyStocks24, Wyatt Investment Research, StockRockandRoll, The Trading Report, PennyStockLocks, Penny Stock 101, Nebula Stocks, BestOtc and Pumps and Dumps reported earlier on Alternet Systems (ALYI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alternet Systems Inc. (OTC: ALYI) is engaged in the provision of marketing intelligence, micro segmentation, data analytics and digital payment services for the telecommunications, financial services, payments and mass consumer goods sectors.

This firm is party to a partnership with iQSTEL Inc., which entails the co-development of 2-way device communication solutions that have been tailored to fit the electric vehicle operating environment. Alternet Systems Inc. operates through its subsidiaries.

The firm, which was founded on June 26, 2000 has its headquarters in Miami Florida and serves consumers in the United States. In addition to this, it also engages in developing and commercializing lithium technologies and provides lithium battery-powered motorbikes and motorcycles.

Apart from offering NFC point of sale solutions to the mobile financial industry, the company also provides financial services software, which includes data analytics tools, payment processing, electronic point of sale modernization, multichannel payment solutions and biometric authentication. The firm also delivers technology solutions to financial organizations that manage payment channels, such as web-based applications, personal computers, tablets, mobile phones and point-of-sale. The enterprise has a large network of industry resources and is guided by executives who’ve specialized in executive and financial management of multi-national organizations, corporate strategy, innovation and entrepreneurial endeavors.

The company recently announced that they’d be expanding their overall electric vehicle ecosystem vision and strategy through a new multitiered deal. This move also includes a new investment into the company, which will substantially contribute to the firm’s balance sheet over the coming period of time, and could be good for the firm’s investors.

Alternet Systems (ALYI), closed Wednesday's trading session at $0.0236, up 24.5383%, on 44,675,171 volume with 1,060 trades. The average volume for the last 3 months is 18.131M and the stock's 52-week low/high is $0.008899999/$0.200000002.

Art’s-Way Manufacturing (ARTW)

Wall Street Resources, SmarTrend Newsletters, QualityStocks, StreetInsider, StockMarketWatch, Marketbeat.com, TradersPro, Zacks, MarketBeat, CRWEFinance, CRWEPicks, CRWEWallStreet, DrStockPick, FeedBlitz, BestOtc, PennyToBuck, StockHotTips, Street Insider, Trading Concepts and PennyOmega reported earlier on Art’s-Way Manufacturing (ARTW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Art's-Way Manufacturing Co. Inc. (NASDAQ: ARTW) is focused on manufacturing and selling agricultural equipment, steel cutting tools and specialized modular science buildings.

The firm has its headquarters in Armstrong, Iowa and was incorporated in 1956. It serves consumers internationally and in the United States. The firm sells and markets its products via original equipment manufacturer sales channels, direct sales, manufacturers’ representatives and independent farm equipment dealers.

The company operates through the Tool, Modular buildings and Agricultural product segments. The tools segment provides cubic boron nitride tools and inserts, polycrystalline and standard single point brazed tipped tools, as well as specialty tools to the oil and gas piping, aerospace and automotive industries. The building segment is involved in the sale, production and lease of research facilities, containment research labs and swine buildings for pharmaceutical and private research firms, public health institutions, government diagnostic and research centers, and academic research institutions. On the other hand, the agricultural segment is engaged in the provision of specialized farm machinery like stationary and portable animal feed processing equipment and forage and hay equipment, which includes silage blowers and reels, reels for swathers and combines, manure spreaders, equipment for harvesting sugar beets, portable grinder mixers, dump boxes, running gears and forage boxes.

The firm is set to launch its new branding initiative and logo for its agricultural products segment, which will update the brand. The move will position the firm as a progressive power player in the agricultural equipment manufacturing industry and may also bring in more investors into the firm, which will have a positive effect on its growth.

Art’s-Way Manufacturing (ARTW), closed Wednesday's trading session at $3.3036, up 3.2375%, on 6,195 volume with 45 trades. The average volume for the last 3 months is 58,671 and the stock's 52-week low/high is $2.04019999/$5.48110008.

Concord Medical Services Holdings (CCM)

SmarTrend Newsletters, MarketBeat, FutureMoneyTrends.com, BabyBulls, CrushTheStreet.com, ShazamStocks, StreetInsider, Marketbeat.com, Vantage Wire, The Street, Zacks, StockMarketWatch, Stock Research Newsletter, The Best Newsletters, AllPennyStocks, MicroCap Press, Streetwise Reports, QualityStocks, Market FN, TopStockAnalysts, FNNO Newsletters, TradersPro, Street Insider, AnotherWinningTrade and MarketClub Analysis reported earlier on Concord Medical Services Holdings (CCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Concord Medical Services Holdings Ltd. (NYSE: CCM) (FRA: C2CA) manages radiotherapy and diagnostic imaging centers.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2007, on November 27th. The firm serves consumers in China.

The company operates through the Hospital and Network segments. It also operates the Beijing Proton Medical Center, which offers radiotherapy treatment options to patients with cancer, as well as other cancer hospitals, which provide surgery, chemotherapy, diagnostic imaging services and radiotherapy services. Its cooperative centers are all equipped with primary medical equipment which includes body gamma knife systems, head gamma knife systems, MRI scanner (magnetic resonance imaging), linear accelerators and PET-CT (positron emission tomography-computer tomography scanner).

Apart from diagnostic imaging services, the enterprise also provides diagnostic services and treatments like tonometry and refraction for diagnosing ophthalmic conditions; stereotactic radiofrequency ablation for treating Parkinson’s disease; thermotherapy for pain alleviation after chemotherapy and radiotherapy; and electroencephalography for diagnosing epilepsy. In addition to this, the company also offers clinical support services, which include the development of treatment protocols for physicians. Furthermore, it is also involved in the sale of medical equipment; the provision of tele-consulting services as well as diagnostic and radiotherapy equipment management and leasing services.

The firm recently began operations at its Guangzhou Concord Cancer Center, which marks a major milestone for the firm. This move increases patient access to treatment and brings the firm one step closer to achieving its goal of building an internationalized cancer center that specializes in clinical diagnosis, treatment, medical research and cancer prevention. This is bound to increase investments into the firm and boost its growth.

Concord Medical Services Holdings (CCM), closed Wednesday's trading session at $2.63, up 0.766284%, on 866 volume with 13 trades. The average volume for the last 3 months is 15,948 and the stock's 52-week low/high is $1.67999994/$5.88999986.

Item 9 Labs Corp. (INLB)

QualityStocks, TopPennyStockMovers and PoliticsAndMyPortfolio reported earlier on Item 9 Labs Corp. (INLB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Item 9 Labs Corp. is a leader in comfortable cannabis health solutions for the contemporary consumer. It is bringing best of industry practices to markets throughout the nation via cultivation and production, distinct retail environments, licensing services, and varied product sets. The Company caters to diverse medical cannabis demographics. Its intention is to manage cultivation, processing, distribution, and also dispensary operations in up to ten United States markets by the end of this year. Item 9 Labs has its head office in Phoenix, Arizona. In addition, the Company has medical cannabis operations in numerous other U.S. markets. Item 9 Labs lists on the OTC Markets’ OTCQX.

The Company’s asset portfolio includes Dispensary Templates, Dispensary Permits, and Strive Life. Dispensary Templates, a subdivision of the Company, is a technology platform with a wide-ranging digital library of licensing and business planning resources.

Dispensary Permits is Item 9 Labs’ consulting firm. It specializes in strategic license application and compliance. Strive Life is a turnkey dispensary model for the retail sector. It improves the patient experience with consistent and first-rate service, high-end design, as well as precision-tested products.

Furthermore, Item 9 Labs has created complementary brands - Item 9 Labs and Strive Wellness - to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, and a pioneering intra-nasal device. The Company has received numerous accolades for its medical-grade flower and concentrates. Its facilities include distribution and processing operations - Strive Wellness of Ohio and Strive Wellness of Nevada, and a dispensary - Strive Life North Dakota.

Item 9 Labs has its Joint Venture (JV) with Third Eye Investments (Phoenix-based). This JV is to expand into the CBD (cannabidiol) extraction and hemp consumer goods marketplace. The partnership is concentrating on the development of Spectrum 8 hemp with planned nationwide distribution and construction of the first solvent free, RF processing extraction facility in North America.

Item 9 Labs Corp. (INLB), closed Wednesday's trading session at $2.2, up 21.547%, on 17,373 volume with 48 trades. The average volume for the last 3 months is 14,426 and the stock's 52-week low/high is $0.788800001/$4.0300002.

NaturalShrimp Incorporated (SHMP)

QualityStocks, PennyPickGains, Pennystockmania, WallstreetSurfers, ThePennyPicks, SmallCapVoice, PoliticsAndMyPortfolio, Wall Street Mover and TopPennyStockMovers reported earlier on NaturalShrimp Incorporated (SHMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

An AquaCulture Company, NaturalShrimp Incorporated produces naturally-grown shrimp in the United States and internationally. It is a leader in the “Closed-System Shrimp Farming” industry. In 2016-17, the Company introduced its patented vibrio suppression technology that is potentially disruptive to the entire shrimp farming industry. NaturalShrimp’s European partner has built a production facility in Medina del Campo, Spain. Expansion plans include domestic and worldwide production facilities and distribution channels. NaturalShrimp is based in Addison, Texas. It has production facilities located near San Antonio, Texas. The Company lists on the OTC Markets’ OTCQB.

NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. NaturalShrimp has developed a technology to produce fresh, gourmet-grade shrimp reliably and economically in an indoor, re-circulating, saltwater facility. Its eco-friendly, bio-secure design does not rely on ocean water. It recreates the natural ocean environment allowing for high-density production that can be replicated anywhere around the world.

The water systems used in production are electrified systems that help to control ammonia and bacteria, killing 99 percent of all bacteria. Shrimp are brought into the facility at 28 days old and are raised until maturity. This happens around 14 weeks of age.

NaturalShrimp Incorporated (SHMP), closed Wednesday's trading session at $0.29, up 31.2217%, on 7,960,659 volume with 1,358 trades. The average volume for the last 3 months is 2.704M and the stock's 52-week low/high is $0.079000003/$0.897000014.

Sona Nanotech, Inc. (SNANF)

We reported earlier on Sona Nanotech, Inc. (SNANF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sona Nanotech, Inc. is a nanotechnology life sciences company based in Halifax, Nova Scotia. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles. The primary business carried out and intended to be continued by the Company is the development and application of its proprietary technology for use in multiplex diagnostic testing platforms that it says will improve performance over existing tests in the market. Sona Nanotech produces high-quality gold nanorod products for diagnostic tests and medical treatment applications. The Company’s shares trade on the OTC Markets’ OTCQB.

Sona Nanotech states that its unique gold nanorods will power the next generation of lateral flow diagnostics. The Company’s gold nanorod products feature a highly functionalized and strong manufacturing process. They are multicolored and CTAB (cetyltrimethylammonium) free. In addition, they have a long shelf life; functionalized surface properties; typical widths are between 10 and 15 nm; and lengths are from 25-60 nm.

Sona’s products include Gemini 650NM, Gemini 700NM, Gemini 750NM, Gemini 800NM, Gemini 850NM, Gemini 900NM, Gemini 950NM, Gemini 1050NM, and Omni. Gemini is for Point of Care diagnostics (lateral flow tests, Elisa, electro-chemical biosensors). Omni is for medical applications (drug delivery, photothermal therapy, and cell imaging).

Concerning Lateral Flow Test Production, Sona is partnered with world-class, third-party manufacturers. This is to manufacture pilot and validation batches through to large-scale bulk volumes to serve a client’s market.

Pertaining to its Conjugation Service, the Company can combine a client’s biologicals with its nanorods to offer a totally optimized conjugate for their assays, reducing their development time. Regarding Lateral Flow Test Development, Sona provides a tailored, modular contract development service from proof of concept through to full development and transfer to production.

Previously, Sona Nanotech announced that its rapid detection, COVID-19 antigen test's laboratory validation studies of performance levels have resulted in a test sensitivity of 96 percent, test specificity of 96 percent, and a Limit of Detection (LOD) of 2.1 x 102 TCID50. Sales of the tests will now be allowed under a 'research use only' label until full regulatory authority is granted, in relevant territories, at which time the 'research use only' label requirement would be lifted.

Technology transfer to manufacturers is now taking place to produce tests to meet present and expected demand. Sona Nanotech said it will provide an update on sales progress and manufacturing delivery timetables in the coming weeks.

Sona Nanotech, Inc. (SNANF), closed Wednesday's trading session at $0.3322, up 27.0849%, on 13,800 volume with 6 trades. The average volume for the last 3 months is 45,878 and the stock's 52-week low/high is $0.179000005/$9.00.

Starco Brands, Inc. (STCB)

QualityStocks and StocksEarning reported earlier on Starco Brands, Inc. (STCB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Starco Brands, Inc. is a consumer packaged goods (CPG) company. It focuses on unique and behavior changing products. The Company develops products across a variety of categories. These include Household Cleaning, Personal Care, OTC (Over-the-Counter), Food, Beverage & Spirits, and DIY (Do-It-Yourself) Hardware. The Company formerly went by the name Insynergy Products, Inc. It changed its name to Starco Brands, Inc. in September of 2017. Starco Brands is based in Santa Monica, California and lists on the OTC Markets’ OTCQB.

Starco Brands’ core competency is inventing technologies, marketing, building trends, pushing awareness, and penetrating media, social and otherwise. In addition, the Company’s core competency is executing leading-edge pull-through strategies with its billion dollar global partners.

Starco Brands has its Breathe® product. Breathe is the first aerosol cleaning line with 100 percent of ingredients meeting the Environmental Protection Agency's (EPAs) Safer Choice criteria. Instead of LPG (Liquified Petroleum Gas), Breathe is powered by air. Included in the Breathe aerosol line is a patent-pending hand sanitizer spray that covers large areas of skin quickly and minimizes human-to-human contact.

The Breathe line includes furniture polish, multi-purpose cleaner, a stainless steel polish, as well as a bathroom cleaner. The Breathe fragrance free hand sanitizer is child resistant with a twist-locking spray tip. It can be used in a wide array of settings. These include households, hospitals, healthcare facilities, airports, transportation terminals, hotels, and other institutions.

Starco Brands previously announced that its Breathe® product line of spray hand sanitizers and household cleaners are now available to purchase online from Amazon and Walmart. The Breathe® line was approved for sale by Amazon after undergoing a 60 day approval process to provide safe and best in class products amid heightened levels of scrutiny. Furthermore, the Breathe Hand Sanitizing Spray and Breathe Household Cleaning line have both earned the Good Housekeeping Seal.

Starco Brands, Inc. (STCB), closed Wednesday's trading session at $0.5, up 25%, on 120,000 volume with 1 trade. The average volume for the last 3 months is 12,240 and the stock's 52-week low/high is $0.305000007/$2.50.

Whiting USA Trust II (WHZT)

StockOodles, QualityStocks, StocksEarning and MarketBeat reported earlier on Whiting USA Trust II (WHZT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Whiting USA Trust II holds a term net profits interest in the oil and gas producing properties located in the Permian Basin, Rocky Mountains, Gulf Coast, and Mid-Continent regions. Whiting USA Trust II is a subsidiary of Whiting Petroleum Corporation. The Company lists on the OTC Markets. Established in 2011, Whiting USA Trust II has its corporate office in Houston, Texas.

As of December 31, 2018, the Company’s oil and gas properties included interests in roughly 367.8 net producing oil and natural gas wells. These are situated in 46 predominately mature fields with established production profiles in 10 States.

The Trust’s net profits interest (NPI), the only asset of the Trust other than cash reserves held for future Trust expenses, represents the right to receive 90 percent of the net proceeds from Whiting Petroleum Corporation’s interests in certain existing oil and natural gas properties located mainly in the aforementioned Rocky Mountains, Permian Basin, Gulf Coast and Mid-Continent regions of the U.S.

The Company’s parent, Whiting Petroleum Corporation, is an independent oil and gas company. It develops, produces, acquires and explores for crude oil, natural gas and natural gas liquids mainly in the Rocky Mountains region of the U.S. The Company’s largest projects are in the Bakken and Three Forks plays in North Dakota and Montana and the Niobrara play in northeast Colorado.

Whiting USA Trust II (WHZT), closed Wednesday's trading session at $0.5, off by 15.2542%, on 167,036 volume with 105 trades. The average volume for the last 3 months is 108,156 and the stock's 52-week low/high is $0.000099999/$0.639999985.

Kura Sushi USA Inc. (KRUS)

MarketBeat, StreetInsider, BUYINS.NET, Trades Of The Day, TradersPro, Schaeffer's, Kiplinger Today and InvestorPlace reported earlier on Kura Sushi USA Inc. (KRUS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kura Sushi USA (NASDAQ: KRUS), a fast-growing technology enabled Japanese restaurant concept, has closed an underwritten public offering of 1,265,000 shares of its Class A common stock, which includes 165,000 shares per the full exercise of the over-allotment option granted to the underwriters. The company secured approximately $57 million in gross proceeds, with each of the shares sold at a public offering price of $45.00. Kura Sushi USA anticipates using proceeds from the offering for general corporate purposes, including capital expenditures, the repayment of the indebtedness outstanding under its existing revolving credit agreement with its parent company, working capital, as well as other business purposes. Roth Capital Partners acted as co-manager for the offering.

To view the full press release, visit https://ibn.fm/Umg2b

Kura Sushi USA is a fast-growing technology enabled Japanese restaurant concept with 32 locations in nine states and Washington DC. The company offers guests a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. Kura Sushi USA was established in 2008 as a subsidiary of Kura Sushi Inc., a Japan-based revolving sushi chain with over 480 restaurants and 35 years of brand history. For more information, please visit www.KuraSushi.com.

Kura Sushi USA Inc. (KRUS), closed Wednesday's trading session at $43.57, off by 3.6914%, on 69,205 volume with 1,222 trades. The average volume for the last 3 months is 69,554 and the stock's 52-week low/high is $11.00/$56.9799995.

The QualityStocks Company Corner

Kaival Brands Innovations Group Inc. (KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

  • Recently uplisted to Nasdaq, trading under symbol “KAVL”
  • KAVL plans to launch proprietary line of CBD products under its Kaival Labs subsidiary, marking the first Kaival-branded product
  • Company sent LOI to potential launch partner for in-house and white-label production

Following its recent uplist to the Nasdaq exchange, Kaival Brands Innovations Group (NASDAQ: KAVL), a company focused on growing and incubating innovative and profitable products into mature and dominant brands, recently announced plans to launch a new line of cannabidiol (“CBD”) products (https://ibn.fm/7Lcd4).
Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products by Bidi(R) Vapor LLC, is in full support of rules and regulations governing the electronic nicotine delivery systems ("ENDS") industry; the company also applauds efforts to enforce those regulations. This support is rooted in Kaival Brands’ own commitment to safeguard youth as well as the confidence it has in providing a safe ENDS product for adult consumers. The BIDI(R) Stick is a top-quality disposable ENDS that complies with all regulations and offers adult consumers a consistent vaping experience. In a show of its support, Bidi Vapor officials recently met with several federal agencies, including U.S. Food and Drug Administration, the Federal Trade Commission, the Bureau of Alcohol, Tobacco, Firearms and Explosives, and the Customs and Border Protection, to encourage increased enforcement. Kaival and Bidi also encourage retailers to focus on youth-access prevention and promotion of compliant brands. To view the full press release, visit https://ibn.fm/7sexK.

Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (KAVL), closed Wednesday's trading session at $6, up 7.5269%, on 15,018 volume with 207 trades. The average volume for the last 3 months is 15,694 and the stock's 52-week low/high is $2.73959994/$43.7999992.

Recent News

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, has announced its participation in the Emerging Growth Conference taking place on Aug. 18, 2021. The real-time, interactive investor conference will feature 10 companies, presenting for 15-45 minutes each. PBI's president and CEO, Richard T. Schumacher, is presenting at the event, briefly expanding on the company's recent announcement that its new eco-friendly, agrochemical subsidiary (PBI Agrochem Inc.) has received over $1,000,000 in purchase orders in its first month of operations. To view the full press release, visit https://ibn.fm/cdhRm

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions — all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $2.74, up 9.6%, on 42,849 volume with 61 trades. The average volume for the last 3 months is 59,659 and the stock's 52-week low/high is $1.28999996/$4.98000001.

Recent News

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The past few years have seen the cannabis industry expand from only cannabis flower and edibles to all kinds of concentrates and infused beverages. Thanks to constantly improving technology, the average cannabis consumer has a wide variety of products to choose from, and at the moment, cannabis-infused drinks are enjoying a surge in popularity. But because cannabinoids such as THC and CBD, which are the chemical compounds responsible for cannabis’ effects, are not water soluble, players in the cannabis industry needed to find a way to infuse cannabis into beverages that ensured consistent product quality and user experience. Emulsion techniques are evolving rapidly, and companies such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are pushing the possibilities to the edge as they make infused drinks.

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverage™ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform (www.A88CBD.com) and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Wednesday's trading session at $1.81, up 1.1173%, on 1,727,832 volume with 6,045 trades. The average volume for the last 3 months is 2.349M and the stock's 52-week low/high is $0.930000007/$2.3499999.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that on Aug. 17, 2021, the stockholders approved an amendment to the company’s certificate of incorporation. The amendment, effective Aug. 17, 2021, increased the number of authorized shares of company common stock from 100,000,000 to 200,000,000. According to the update, the approval was granted at the special meeting of stockholders convened on Aug. 10, 2021, and adjourned to Aug. 17, 2021. To view the full press release, visit https://ibn.fm/KL4Vf

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $1.08, up 5.8824%, on 1,291,402 volume with 2,717 trades. The average volume for the last 3 months is 2.757M and the stock's 52-week low/high is $0.629999995/$2.29999995.

Recent News

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC)

The QualityStocks Daily Newsletter would like to spotlight BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has received multiple product listings and purchase orders from Alberta Gaming and Liquor Commission (“AGLC”). The initial order includes international bestsellers Keef and Green Monké products as well BevCanna’s new brand, State B Beverages. The products are slated  to be on the shelves of more than 600 licensed private retailers by the fall; the products will also be available online. AGLC is the government of Alberta's agency that oversees the gaming, liquor and cannabis industries in Alberta; the agency also operates the province’s only legal, nonmedical online cannabis store. To view the full press release, visit https://ibn.fm/EVSiQ

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale.

BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands.

Based in British Columbia, Canada, BevCanna was founded in 2017.

End-to-End Turnkey Beverage Manufacturing Solutions

BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

  • Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
  • Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
  • Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
  • Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
  • Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands

BevCanna’s in-house brands include Pure Therapy and TRACE.

Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (CBD) products, throughout North America and Western Europe.

Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise.

TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels.

Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness.

TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots.

In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages.

Market Outlook for Cannabis-Infused Beverages

In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (https://ibn.fm/VkJfH).

The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces.

Management Team

Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand.

John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd.

Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years.

Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise.

Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL).

Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years.

Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries.

Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY).

BevCanna Enterprises Inc. (OTCQB: BVNNF), closed Wednesday's trading session at $0.3404, up 7.314%, on 112,901 volume with 66 trades. The average volume for the last 3 months is 157,470 and the stock's 52-week low/high is $0.125/$1.20000004.

Recent News

Perpetual Industries Inc. (OTC: PRPI)

The QualityStocks Daily Newsletter would like to spotlight Perpetual Industries Inc. (PRPI).

Perpetual Industries (OTC: PRPI), an incubator for the development of new and innovative energy-efficient technologies and products, today announced highlights of its financial and operating results for the second quarter ended June 30, 2021. Among the highlights, the company reported recorded revenues of $2,678,361, gross profits of $1,102,822 and cash of $1,605,259, a 172% increase over year ending December 2020. “We are very pleased with our continued improving financial performance during the second quarter. The results again demonstrated our growing potential as we continue to leverage the strengths of our subsidiary and divisions,” said Brent Bedford, Perpetual’s chief executive officer. “We delivered increased growth for the second quarter in a row while making significant progress in the development of our blockchain and new AutoGrafic software divisions.” To view the full press release, visit https://ibn.fm/4f9EP

Perpetual Industries Inc. (OTC: PRPI) is an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale.

The company’s team of experts and trusted industry partners have the resources to provide essential components needed to take projects from their initial stages through to the end products. Perpetual Industries values strict controls and high levels of quality through all stages of research, development, manufacturing and commercialization.

Perpetual Industries was founded by President, Chairman and CEO Brent W. Bedford in 2005. It is located in Auburn, Indiana.

R&D Portfolio Overview

Perpetual Industries is expanding expertise and knowledge of energy-efficient technology by developing low-cost, green energy solutions for various industries, including artificial intelligence, blockchain mining, graphic rendering, renewable energy, cloud computing and internet of things (IoT), all while continuing research, development and commercialization of its proprietary XYO Balancing Technology in key applications.

XYO Balancing Technology

XYO Balancing Technology delivers high-performance solutions for inefficiencies that commonly affect rotating equipment, machinery and devices. It is designed to harness rotor displacement energy to move compensating masses and automatically correct for imbalances, effectively reducing vibration.

Key highlights of the company’s XYO Balancing Technology include:

  • Customized XYO balancers can be created for almost everything that rotates, providing virtually unlimited potential applications.
  • XYO Balancing Technology is optimized specifically to eliminate vibration in rotating equipment and enable environmentally responsible products to operate more efficiently.
  • Leveraging a proprietary design, XYO Balancing Technology is the result of over 25 years of research and development effort.

WindSilo – Vertical Axis Wind Turbine

Implementing its proprietary XYO Balancing Technology, Perpetual Industries’ WindSilo turbine improves balancing issues that are common in most wind turbines today. The company’s design is engineered to allow for much faster spin speeds and greater energy output.

The company believes that this innovative turbine design could eliminate the expensive traditional methods of balancing wind turbines while increasing their performance, reliability and efficiency.

In November 2020, Perpetual Industries announced that Trine University, a private post-secondary institution located in Angola, Indiana, had been awarded a grant to assist the company in the development of the WindSilo.

The XYO Washing Machine

Perpetual Industries is currently developing a proprietary domestic washing machine design implementing XYO Mechanical Balancers to dynamically compensate for variable mass imbalance during the spin cycle. The company expects these efforts to produce a number of benefits, including higher spin speeds, reduced energy consumption, decreased noise emissions and less mechanical wear & tear.

The company’s research shows tremendous market potential for a more efficient washing machine design. With an estimated 70 million washing machines produced annually and over 500 million used daily, even a small reduction in energy consumption could be pivotal. Reducing energy usage of all washing machines by just 15% would save enough energy to power the city of Milan. Perpetual Industries’ energy efficient design is expected to reduce energy usage by up to 50%.

Prototype testing of Perpetual Industries’ design has established the XYO Washing Machine as highly effective at reducing vibration when built into the spin basket assembly.

Green Energy Mining System

Using its expertise and knowledge of environmentally friendly technologies, Perpetual Industries is developing low cost, environmentally responsible energy solutions for powering large scale blockchain mining operations.

The company’s Green Energy Mining (GEM) System is being hailed as the next generation of energy efficient cryptocurrency mining. Powered by renewable & surplus energy sources such as wind, solar, natural gas, wind and geothermal that utilize battery storage technology, the platform addresses rising demand for computing power.

Renewable Energy Market Outlook

The global renewable energy market was valued at $928 billion in 2017 and is expected to continue expanding at a CAGR of 6.1%, resulting in a value of $1.5 trillion by 2025, according to Allied Market Research (https://ibn.fm/C06xF). Hydroelectric power is projected to be the most lucrative segment of the entire global renewable energy industry, followed by the wind, bioenergy, solar and geothermal segments.

Worldwide Auctioneers Acquisition

In January 2021, Perpetual Industries announced its acquisition of The Worldwide Group LLC, operating as Worldwide Auctioneers.

Worldwide Auctioneers is a U.S.-based boutique auction firm specializing in the sale and acquisition of classic vintage motorcars at auction around the globe. With an impressive 20-year history and a talented team, Worldwide offers an extensive range of personalized services to collectors, including private sales, appraisal, collection direction and consultancy, estate planning and asset management.

Perpetual Industries expects Worldwide to benefit from multiple channels of collaboration moving forward, particularly within the company’s blockchain division.

Classic Car Market Outlook

The U.S. classic car market has recorded steady expansion over recent years, accounting for revenue of approximately $12.63 billion in 2020, according to Statista (https://ibn.fm/Fydhj). The same report forecasts growth to $15.52 billion by 2023, representing a CAGR in excess of 7 percent. Classic car dealers in the U.S. have cornered a significant portion of this market opportunity. According to data from IBISWorld (https://ibn.fm/k30F5), the market for classic car dealers in the U.S. was valued at $2.1 billion in 2021, achieving a CAGR of 1.5% from 2016 to 2021, despite the challenges associated with the COVID-19 pandemic.

Management Team

Brent W. Bedford is the President, Chairman, CEO and founder of Perpetual Industries. He has held these roles continuously since founding the company in January 2005. He has a deep understanding of every aspect of the company’s business, products and markets. He also has experience developing corporate strategies, assessing emerging industry trends and carrying out business operations. Mr. Bedford has a strong background in mechanical applications, with expertise in finance, private startups, public startups and corporate turnarounds.

Carl Dilley is Director and COO of the company. He is a career entrepreneur who has served as a C-level officer in many different companies across multiple industries. Mr. Dilley has been instrumental in taking over 400 companies public. He has been involved in the investment industry since 1983. He has held FINRA series 24, 66 and 7 Securities licenses, allowing him to perform retail, investment, banking and new listing services functions.

William Griffin Thomas, CPA, is the company’s CFO. He holds a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. Mr. Thomas is a licensed CPA with over 19 years of experience spanning both the private and public sectors, as well as time with non-profits. His expertise includes auditing, budget analysis, fixed assets, financial modeling, SEC financial reporting, GAAP compliance and fair value measurements.

Perpetual Industries Inc. (PRPI), closed Wednesday's trading session at $0.22, up 46.6667%, on 3,295 volume with 3 trades. The average volume for the last 3 months is 13,296 and the stock's 52-week low/high is $0.063000001/$0.925000011.

Recent News

Emaginos Inc.

The QualityStocks Daily Newsletter would like to spotlight Emaginos Inc..

Emaginos, a REG-A public company (please see website if interested in investing) in the business of transforming K-12 public education, is committed to fixing the nation’s educational system through its proprietary Discover Learning System (“DLS”). A recent article, which contains excerpts from a recent blog by Emaginos president Allan Jones, noted that the company is seeking $3 million to begin the transformation of the K-12 education system. According to the blog, Emaginos is committed to solving two major problems. “The first is fixing . . . the outdated and test-bound K-12 public school system. The second is enabling teachers and parents to benefit financially from the transformation — doing good while doing well. . . . Doing good refers to behaving altruistically or charitably. Doing well refers to being financially secure. Looking at Maslow’s Hierarchy tells us that intrinsically we have to focus on doing well before we can consider doing good. Investing in Emaginos provides an opportunity to do both simultaneously.” To view the full article, visit https://ibn.fm/1Bnas

Emaginos Inc. is working to improve the education system of the United States through a commitment to integrated, proven best practices. Opposed to replacing public schools with charter schools, Emaginos believes in restoring neighborhood schools and having them serve as focal points of their communities.

Through the company’s model, one school in a district is transformed into a charter. This allows the district to write a separate contract for the teachers in the pilot school. The pilot school incorporates the new model into the community and proves the concept. The lessons learned from this charter are then used to transition the model to the other public schools, adapting them to the model while remaining public.

To achieve this transformation, Emaginos provides the schools with a wealth of resources ranging from technology infrastructure to curriculum training. The schools transformed by the model operate with economic efficiencies squarely in mind, resulting in a better educational experience for the same or lower overall cost.

The company is a REG-A+ Tier 2 public company raising capital for future development and deployment of its transformational public-school model, with the goal of changing the way public schools approach learning.

Emaginos was founded in 2008.

Program Elements

The Emaginos program provides various elements aimed at making the model successful, including:

  • Learning Environment: Integrated and proven best practices, multi-level classrooms, diverse small group settings, magnet programs, etc.
  • Curriculum: Education customized for individuals, no textbooks, observational assessment rubrics, no more teaching to the test, STEM integration, etc.
  • School Calendar: Longer school day, longer school year, internships, college courses, etc.
  • Staffing: Teacher mentoring, highly qualified teachers, teacher pay, union support, etc.
  • Technology: Technology integration, videoconferencing and telepresence, administrative software, student technical support, etc.
  • Wellness and Primary Health Care: Telemedicine, primary health care, wellness simulations, etc.
  • Scalable and Transformational: Operates within existing budgets, accountability, research center, national leadership, etc.
  • Additional Benefits: Grassroots, unanimity planning, dropout prevention, attendance, etc.

Emaginos Investment Model

Emaginos is focused on changing the way that public school transformation is approached. While many in the industry are in favor of the transition to charters or homeschooling, the company believes in keeping the same buildings and teachers while implementing new proven best practices within the existing budget.

Some key figures relating to the public school system include:

  • There are 98,328 public K-12 schools.
  • Total public-school enrollment exceeds 50 million.
  • The public school system employs more than 3.1 million teachers.
  • Total funding of public education amounts to roughly $597.5 billion, with federal funding accounting for 12.7%, state funding accounting for 43.5% and local funding accounting for 43.8% of the total.

The Emaginos model is not a one-time product sale; it is a subscription service that provides the necessary resources for the public school to transition from traditional “teaching and testing” models to the “learning and doing” model.

The Cost of the Emaginos Model

Emaginos’ start-up costs are significant as it builds the EdManage platform and its student centered, multidisciplinary, textbook-free, learning-team, project-based curriculum. However, after the platform and curriculum are built, the company expects to incur relatively small incremental costs to sell, deliver and support the program.

Even though districts are required to pay for the model and annual subscription, overall, they are expected to come out even or on top in terms of expenditure. With no more textbooks and no need for additional technology, schools can go without extra support staffing, allowing for additional cost savings.

Management Team

Dr. Keith Larick is the man who developed the Emaginos plan. As a superintendent within the Tracy Unified School District (TUSD) 20 years ago, Dr. Larick chose three educators with whom to work, with the goal of changing education. He challenged these educators to take a clean slate approach to design the optimal K-12 education program. Using proven student-centered and organizational best practices, the result was the creation of three charter schools proving the new K-12 model.

Allan Jones is the President of Emaginos Inc. He has spent over 40 years working in and around education. He was a classroom teacher, district chief information and technology officer in the public school system, and taught college courses for teachers. Mr. Jones also served as a school board member. He co-founded an online high school, consulting with school districts on technology planning, and worked for Digital Equipment Corporation’s corporate research division. While there, he created programs to identify and transfer ideas from leading universities into the company. After all those years of seeing the good, bad, and ugly within the American public school system, he joined Dr. Larick to transform America’s schools into centers of discovery and innovation.

The late Jack Taub was the Chief Visionary of Emaginos Inc. He was from Brooklyn, New York, and dropped out of school to pursue a passion for stamp collecting. He and his brother Bert, both respected philatelists, developed a successful stamp selling business. At one time, they even had an exclusive contract with the USPS, selling their stamp-collecting materials across the country. From those earnings, the brothers invested in what would be considered one of the first social networking applications – though the term didn’t exist yet. Neither brother had a good experience within the K-12 school system, so they turned their sights on fixing it. They teamed up with Dr. Larick to design new models for education adhering to the idea that all students can succeed in education.


Recent News

chart

Streamlytics

The QualityStocks Daily Newsletter would like to spotlight Streamlytics

Streamlytics today announced its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. The piece, titled, “Third-Party Cookies Are Toast, First-Party Data in Demand as Consumers Clamor for Privacy,” discusses new modalities that cater to security and privacy in the era of “big data.” “Nothing is more representative of the ongoing shift than Apple’s recent operating system changes that feature one of the world’s few welcomed pop-ups: one that asks if it’s okay to track your activity,” reads the publication. “Welcome to the age of ‘small and wide’ data. Companies are already looking to next-generation technology to meet this new demand, including that of Streamlytics, which doesn’t use cookies or tracking in its human-led data.” To view the full press release, visit https://ibn.fm/5C8JB

Streamlytics provides ethical, people-powered data, spanning millions of data points from today’s fastest growing communities across the United States. The company unlocks the power of actual data usage, reflective of how people create data today – simultaneously across all types of platforms, not by rigid panels or unethical tracking. By partnering with consumers across the nation, the company has gained unparalleled access to audiences’ and shoppers’ content consumption and purchasing patterns across Netflix, Google, Amazon and more.

Streamlytics’ first consumer facing data acquisition app allows African American consumers to own their data through a data license, value their data with its proprietary data valuation algorithm, and get fairly paid for their data. The result is ethical data transactions and unmatched insight into the decisions that consumers are making across platforms. The company’s data signals are not limited to purchase and content consumption. The breadth of activity spans fitness, health and universal mobility. The current archaic model of consumer data collection across many industries is to use second- or third-party assumptive data based on cookies or affinities, which has a high margin of error causing an enormous amount of waste in financial resources for client organizations. Streamlytics provides clear, accurate, full-spectrum data, delivering the true picture of a coveted consumer group’s activity across their digital footprint.

Since its founding, the company’s mission has been to disrupt the deceptive online data collection processes that have become commonplace. Streamlytics’ drive to prioritize consumer data collection transparency and ethics has led to tremendous growth. The company recently announced it had reached a milestone of more than a quarter-billion data points. Streamlytics’ impressive growth over the past year is largely due to expansion, adding platforms like Apple, Uber, Uber Eats, Postmates and others. The company’s patent-pending data standard, Universal Data Interchange Format (UDIF), powers the unification of cross-platform data sources and formats into a single unified data format. Streamlytics leads the industry in consumer data unification, which is increasingly valuable as companies look to navigate away from third-party data solutions and integrate ethical first-party data across corporate strategy, product innovation, artificial intelligence, marketing and more.

How it Works

Streamlytics unifies consumer data from today’s fastest growing communities across popular platforms spanning over 400 million data points. We ethically unlock the power of actual usage data (directly from the source) and help companies grow by enhancing their 1st-party data strategy across sales, marketing, product, and artificial intelligence.

Streamlytics data enhances existing measurement tools by focusing on density. The company’s approach provides a number of benefits over traditional data sourcing platforms, including:

  • Multidimensional data that offers visibility into consumption behaviors that define decision drivers for consumers
  • An integrated approach that connects a variety of data sources and types to paint the clearest picture of consumer behavior
  • A clear understanding of the consumer, allowing for greater targeting precision that directly impacts the effectiveness of campaigns
  • Ethical sourcing, with consumers directly compensated for their data
  • Protection of all personal identifying information (PII) to ensure privacy and security

The company sells data that has been ethically sourced through a Standard Datastream (a streamlined feed consisting of roughly 22.5 million data points) and a Custom Datastream (a full spectrum feed spanning over 150 million data points). Client organizations subscribe to either datastream, based on the specific audiences they want to reach. Organizations most often use Streamlytics data to enhance their first party data strategies in an effort to increase revenue and sales, refine corporate strategy and enhance machine learning training data to reduce algorithmic bias.

Market Outlook

The global alternative data market was valued at $1.06 billion in 2019 and is expected to grow at a CAGR of 40.1% to reach more than $8 billion by 2027. The global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to achieve a CAGR of 40.2% from 2021 to 2028, according to data from Grand View Research.

Streamlytics believes a new market space is emerging at the intersection of these two thriving industries called ‘Community Driven Data’, which will comprise consumers who have opted in to share their data, and companies that decide using ethically sourced data is better than fines and negative media coverage they could get from continuing to do it the old way.

Streamlytics has positioned itself as the leader of this emerging new market space as consumers increasingly opt out of sharing their data under the current model, and as new laws – like Prop 24, the California Consumer Personal Information initiative passed overwhelmingly by voters in 2020 – mandate greater privacy protections for, and limits on corporate use of, consumer data.

Management Team

Angela Benton is founder and CEO of Streamlytics. She is a pioneer of diversity in the technology industry and of raising awareness around the inequalities that exist in the industry. In 2011, she founded NewME, the first entrepreneurial accelerator globally for minorities. Through her leadership, NewME has accelerated hundreds of entrepreneurs, helping the nascent companies to raise more than $47 million in venture capital funding. That company was acquired in 2018.

Arisha Smith is the Chief Revenue Officer of Streamlytics. An innovator in advertising technology, she has designed growth strategies for businesses leveraging digital, social and mobile platforms for over 20 years. She has held marketing positions at Accenture and Microsoft, as well as at Vibe Media. She earned an MBA from Florida A&M University.


Recent News

chart

StorEn Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight StorEn Technologies Inc.

StorEn Technologies is behind a disruptive, patent-pending, all-vanadium flow battery technology, which answers the call for long-lasting, 100% recyclable, safe, and affordable energy storage. A recent article contains excerpts from a recent StorEn blog in which the company discussed the benefits of vanadium flow batteries. “According to StorEn, vanadium flow batteries offer superior discharge capacity and a long lifespan,” reads the article. With vanadium flow batteries, 100% of the initial battery capacity is always available throughout the entire lifespan of 25 years or more. They are also safer, low maintenance and more versatile. “‘At StorEn Technologies, we believe that vanadium flow batteries are the key to making sustainable energy sources like solar power more widely accessible,’ states the blog, which outlines why the benefits of vanadium flow batteries make them ‘uniquely suited to the task of rolling out renewable energy on a larger scale and helping more people and businesses achieve independence from the electric grid.’” To view the full article, visit https://ibn.fm/bSscr

StorEn Technologies Inc. delivers proprietary vanadium flow batteries aimed at revolutionizing the world of residential and industrial energy storage. With an expected life of 25 years and more than 15,000 cycles, the company’s batteries satisfy market demand for efficient, durable and cost-effective energy storage, enabling self-consumption of self-produced electricity and the transition toward a carbon-free economy.

The company is currently accepting investments through a Reg A+ offering on StartEngine. For more information, view the company’s Offering Circular. To date, StorEn has raised more than $6.7 million from over 5,000 investors on the crowdfunding platform, along with venture capital from the ANYSEED Fund.

StorEn’s growing intellectual property portfolio currently features four international PCT patents and five trademarks, securing its innovative IP in all major regions and countries in the world.

A Disruptive Approach to Energy Storage

StorEn’s patent-pending all-vanadium flow battery technology offers a variety of benefits over existing lithium and lead acid batteries, including:

  • Eco-Friendly: StorEn vanadium flow batteries are 100% recyclable, featuring a 100% reusable electrolyte and low GHGs emissions.
  • Safe: The company’s batteries are both non-flammable and non-explosive.
  • Cost Effective: StorEn’s cost/kWh is comparable to that of lithium batteries, but its cost/cycle is up to four times lower than lithium batteries, thanks to the exceptional duration of over 25 years or 15,000 cycles.
  • Efficient: The company’s vanadium flow battery technology offers the highest power density thanks to MULTIGRIDS™, +35% in energy storage capacity with the same volume and +5% round-trip efficiency in harsh climate thanks to its proprietary THERMASTABLE™ geothermal design. StorEn’s solution is also virtually maintenance-free, leveraging its proprietary RESAFE™ and EQUILEVELS™ technologies.

StorEn batteries are modular and configurable in either 20kWh or 30kWh versions sharing the same Power Module, ensuring that customers only pay for the energy capacity they really need. The ability to connect additional modules allows for maximum flexibility.

Traction in the Market

To date, the total investment in the company’s technology has exceeded $2 million, and it is already putting these efforts to work. StorEn secured a $500,000 order in Australia to provide 30 kWh StorEn vanadium flow batteries to a renewable hydrogen plant at Queensland University of Technology (QUT), where researchers will develop safety standards for the future use of vanadium flow batteries. The first battery – the first of its kind in Australia – was installed in Brisbane in November 2020 at the National Battery Testing Centre (NBTC), a flagship project of the Future Battery Industries CRC. Additional units are being manufactured.

StorEn has also entered into a supply chain deal with Multicom Resources, an Australian mining company which is the owner of two vanadium mines. Through this agreement, StorEn has secured the exclusive availability of vanadium for up to 20 years with either a price cap or at market price, whichever is lower.

Capitalizing on the Australian government’s support to fulfil the country’s energy storage opportunity, Multicom’s subsidiary, Freedom Energy, has agreed to assemble StorEn batteries within Australia and distribute them widely across the wider Asia Pacific region. In addition to an initial pilot plant, Multicom has completed a concept design for a full-scale manufacturing facility for StorEn batteries.

Market Opportunity

The shift to renewable energy sources is on, with governments around the globe discussing and implementing initiatives to reduce dependence on fossil fuels. McKinsey & Company research suggests that, by 2035, more than 50% of global power generation will come from renewable sources.

Spurred on by this transition, demand for reliable energy storage systems is expected to attain exponential growth in the coming years, positively influencing the energy storage industry landscape, according to Grand View Research.

Data from Fortune Business Insights projects that the global battery energy storage market will reach $19.74 billion by 2027, recording a CAGR of 20.4% from 2020 to 2027. The research firm suggests that improving access to electricity across the globe will be a prominent trend shaping the growth trajectory of this market, which is particularly noteworthy for StorEn and its TITANstack™ grid-scale energy storage solution.

Over a billion people still do not have access to electricity. The electrification of these unserved communities can become a reality with mini grids, using solar plus energy storage. StorEn’s vanadium flow batteries could be a key technology toward providing universal access to affordable, longer lasting and dependable energy. In support this critical mission, StorEn Technologies is a member of the Alliance for Rural Electrification and the Global Off-Grid Lighting Association.

Management Team

StorEn is led by an executive team with decades of experience in the vanadium flow battery industry.

Founder Carlo Brovero has served as the company’s chief executive officer, treasurer and director since its inception in January 2017. From 2013 to 2019, Mr. Brovero served as a consultant for eCaral Ltd., a management consulting firm. From 2013 to 2015, he served as an advisory board member for Proxhima S.r.l., a vanadium flow battery company, which was sold to the Gala Group, a utility listed on the Milan Stock Exchange. From 2010 to 2016, Mr. Brovero served as International Sales and Marketing Director for iVis Technologies, the manufacturer of an excimer laser therapeutic and refractive platform for corneal surgery. He holds an MBA from Aston University in Birmingham, UK.

Founder Angelo D’Anzi has served as StorEn’s chief technology officer and director since the company’s inception. He is primarily responsible for the technical development of StorEn’s products. Since May 2018, Mr. D’Anzi has also served as a director of Arco Fuel Cells S.r.l., where he is responsible for the company’s fuel cell technical development activities. Mr. D’Anzi co-founded vanadium flow battery company Proxhima in 2013. In 2000, he founded ROEN-EST, a fuel cell company that was eventually acquired by the Morphic Group, a cleantech holding company listed on the Stockholm Stock Exchange. Mr. D’Anzi holds 14 international patents and received the 2003 Sapio Award in the Energy and Transportation category. He holds an MBA from the LUISS Business School in Rome.

Founder Gabriele Colombo has served as secretary of StorEn since its inception. Since 2012, he has also served in various roles ranging from regional manager to CEO with Leonardo Hispania S.A., a subsidiary of the Leonardo Group of Italy, an aerospace, defense and security conglomerate. Mr. Colombo co-founded vanadium flow battery company Proxhima in 2013. He holds an honors degree in computer engineering from the University of Pisa and a master’s degree in business leadership from the University of Genova.


Recent News

chart

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC)

The QualityStocks Daily Newsletter would like to spotlight AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC).

At the onset of the pandemic, restrictions on moving around were implemented, with social distancing and other measures being taken to avoid virus spread. As people have adjusted to a “new”  normal, fewer and fewer individuals have been returning to their physicians for their annual cancer screenings. Cancer screening is basically getting checked for cancer by your physician before you begin displaying any symptoms. The importance of screening for and detecting cancer as early as possible has prompted many firms such as AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) to develop novel ways to detect cancer even before a single tumor has formed so that patients can have a fighting chance of beating the condition.

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) is a biotechnology company focused on early cancer screening and detection. The company develops, distributes and deploys accessible early disease detection devices with an aim of changing the way people approach cancer screening. AnPac Bio-Medical is a highly innovative company and an early thought leader and developer of multi-cancer screening technology, which is gaining significant acceptance.

AnPac Bio-Medical has clinical laboratories in the United States and China, with 142 issued patents as of March 31, 2021. Its corporate headquarters is located in Shanghai, China, while its U.S. headquarters is situated in Philadelphia, Pennsylvania. The company operates two certified clinical laboratories in China and one CLIA registered clinical laboratory in the United States.

Cancer Differentiation Analysis (CDA)

Cancer Differentiation Analysis (CDA) is AnPac Bio-Medical’s approach to detecting cancer and pre-cancerous diseases. CDA uses the natural biophysical properties of blood and cellular proteins to discover cancerous environments before the tumors even form.

Most liquid-based cancer screening and detection technologies focus on biochemical signals, like conventional biomarkers and genomic signals, such as ct-DNAs and CTCs (circulating tumor cells in the blood). These typically only determine whether or not cancer has occurred at a fixed point in time.

CDA technology combines an assessment of existing biomarkers with the biophysical properties and cellular proteins that signal the lead-up to serious health conditions and cancer. It is also used to pinpoint where cancer is most likely located and predict where the risk is highest in the future – all through a standard blood test, at a competitive price point.

AnPac Bio-Medical’s CDA is powered by a database of over 200,000 samples and cases and serves as a new way to approach disease and cancer screening. The device uses an integrated system of sensors to detect several biophysical signals at the cellular, protein and molecular levels. CDA leverages a proprietary algorithm to synthesize the data, effectively generating a personalized risk assessment for evaluated patients.

Through CDA technology, AnPac Bio-Medical aims to address a number of goals, including:

  • Innovate – AnPac Bio-Medical is an innovator in the cancer screening industry, with CDA research ongoing since 2008, and commercial operations beginning in 2015. AnPac considers itself a thought leader in developing multi-cancer screening.
  • Detect – AnPac Bio-Medical detects early signals of threatening cancer and its location within the body.
  • Identify – CDA identifies the risks of up to 26 different types of cancers with high sensitivity and specificity rates.
  • Provide – The company’s platform provides multi-level, multi-parameter analysis using proprietary diagnostic algorithms, which results in accurate and easy-to-understand results.
  • Proven – A fully operational analysis of over 200,000 test samples has been run to date. CDA technology has been shown to identify pre- and early-stage cancers in patients previously diagnosed as “cancer-free” through traditional methods.
  • Biophysical Properties – CDA analyzes biophysical properties in human blood and the correlation between biophysical properties and cancer occurrence.

Market Outlook

AnPac Bio-Medical is exploring detection of other types of cancers leveraging its innovative CDA technology and multi-cancer screening and detection tests, which could open significant opportunities on the global cancer diagnostics market.

According to a report by Grand View Research, the cancer diagnostics market is expected to reach $249.6 billion worldwide by 2026 (https://nnw.fm/L7css). The market is expected to grow at a CAGR of 7% during the forecast period.

Management Team

Dr. Chris Yu is the Co-Founder and Chief Executive Officer of AnPac Bio-Medical. He has enjoyed a successful career as an innovator in life sciences, technology and engineering. Dr. Yu has worked for three U.S. Fortune 500 companies and is the first/principal inventor of over 300 patent applications spanning semiconductors, materials and life science. He has a proven history of developing cutting-edge products with long-term profit and sustainability. Dr. Yu was born to a medical doctor’s family and went to medical school. He later switched his major to physics and received his bachelor’s and master’s degrees in physics from the University of Missouri-Kansas City Campus and a doctoral degree in physics from Pennsylvania State University. Both of his dissertations addressed innovative detection techniques.

Dr. Herbert Yu is the Co-Founder and Chief Medical Officer of AnPac Bio-Medical. He is a renowned expert in molecular epidemiology, with training in medicine and chemical biochemistry. Dr. Yu has a 20-year career in leading-edge cancer research, including breakthrough work in areas of carcinogenic factors. He is a professor and research director at the University of Hawaii and an adjunct professor at Yale University. He received his bachelor’s degree in medicine from Shanghai First Medical College. Dr. Yu also received a science degree in epidemiology and a Ph.D. in clinical biochemistry from the University of Toronto.

Jingiu (Edward) Tang is the company’s Chief Financial Officer. He previously served as a global internal auditor at Natuzzi S.p.A. Mr. Tang also worked at Beijing Dongshen CPA and Shanghai De’an CPA, providing external audits, finance and tax advisory services across different industries and sectors. He is a Certified Public Accountant in Australia. Mr. Tang received his bachelor’s degree in accounting from Charles Sturt University in Australia, his MBA from Charles Sturt University, and his bachelor’s degree in law from Southwest University of Science and Technology in China.

Weidong Dai is the company’s China General Manager. He previously served as a general partner at Stirrfir Investment Management Co. Mr. Dai has also served as the chairman of RTS Management (Shanghai) Co., and as managing director of Hong Kong Pro-Health Technology Co. and Shanghai Pro-Health Medical Devices Co. He has published a number of medical research papers and research articles in professional journals. Mr. Dai was awarded the Hong Kong Industrial Award for a medical device that he led in research and development. He earned his bachelor’s degree in medicine from Anhui Medical University, a master’s degree in medicine from the Sun Yat-San University of Medicine, and an Advanced Certificate of the EMBA CEO Program from Fudan University, School of Economics.

AnPac Bio-Medical Science Co. Ltd. (ANPC), closed Wednesday's trading session at $3.6, off by 2.1739%, on 23,962 volume with 192 trades. The average volume for the last 3 months is 1.046M and the stock's 52-week low/high is $3.15000009/$12.0900001.

Recent News

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF)

The QualityStocks Daily Newsletter would like to spotlight TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF).

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) announced that, in only two months, its flagship product TAAT(TM) has been picked up for distribution in seven new U.S. states; the most recent states carrying the product are Alabama, California, Florida, Michigan and Mississippi. A few weeks ago, the company signed a distribution agreement that included Georgia; Illinois is also now carrying TAAT products. These states join Ohio, where the product was originally launched. TAAT tobacco-free and nicotine-free alternative to traditional cigarettes is also available online through the company’s e-commerce operations. In addition, the company has announced plans for its game-changing product to be available in the United Kingdom and Ireland. To view the full press release, visit https://ibn.fm/RzmA1

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) is a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco.

The key players of TAAT Lifestyle & Wellness are from leading tobacco brands. They are guiding the mission with the company’s proprietary product, TAAT(TM), which uses the company’s proprietary Beyond Tobacco(TM) base material. The base material undergoes a 14-step process to taste and smell just like tobacco and uses a patent-pending refinement technique.

This provides the company with unique opportunities on the global tobacco market, which was estimated at $849 billion in 2019, with approximately 1.3 billion people using tobacco in some form worldwide (https://nnw.fm/bvKFL).

TAAT Lifestyle & Wellness was founded in 2006 and is headquartered in Vancouver, Canada, with operations in Las Vegas, Nevada.

TAAT(TM)

TAAT is a smokable alternative to tobacco cigarettes using the Beyond Tobacco base material, which contains zero tobacco and zero nicotine. The current TAAT offering comes in three varieties: Original, Smooth and Menthol, which were launched during Q4 2020 in Ohio. The company’s Ohio tobacco wholesaler also distributes for major tobacco industry names such as Altria, RJ Reynolds (a subsidiary of British American Tobacco) and ITG.

The TAAT Beyond Tobacco experience was created to replicate the sensory elements of smoking a tobacco cigarette. Market testing in California and Nevada reached a consensus that TAAT products offered no significant differences in experience when compared to tobacco cigarettes, in terms of the following aspects:

  • Visual – the nearly identical product packaging and enhanced smoke volume
  • Auditory – the “crackling” sound of the base material when it is ignited
  • Smell – when burning, TAAT emits a tobacco-like scent
  • Taste – the patent-pending Beyond Tobacco base material undergoes a refinement process that creates a tobacco-like taste
  • Touch – TAAT satisfies the “hand-to-mouth” fixation and motor habits, such as flicking ashes

TAAT Beyond Tobacco Targeting Current Smokers

TAAT Lifestyle & Wellness is currently targeting the market of legal-aged smokers with its proprietary product. The company aims “not to create a new problem, but to solve an existing one.” TAAT Lifestyle & Wellness offers a non-addictive alternative to tobacco, with several competitive advantages making it a promising option on the United States market, such as:

  • Price – TAAT can be offered at a lower price than competing products in the tobacco category, which adds to the propositioned value for current legal-aged smokers.
  • Experience – TAAT appeals to current smokers who wish to give up the tobacco and nicotine but keep the smoking experience they enjoy.
  • Branding/Packaging – TAAT is American-grown and American-made, with its Beyond Tobacco base material serving as a legacy to the combustible tobacco products.

The current alternatives to cigarette smoking do not offer a comparable experience. Previously marketed products, like vaping, proved difficult for some legal-aged smokers to adopt, as the experience was too different from traditional cigarettes.

Market Outlook

In 2016, the United States tobacco market was valued at over $100 billion, a number that’s expected to grow over the next decade (https://nnw.fm/yd8oP). In terms of volume, over 215 billion cigarettes were sold to roughly 34 million adults in the United States in 2018. These numbers represent almost 14% of the adult population. Of those, almost two-thirds smoked more than 15 cigarettes in one day. A standard pack is comprised of 20 cigarettes.

The company’s Beyond Tobacco, as a non-tobacco product, has a price-driven consumer advantage in many states. While state taxes on traditional cigarettes vary, most tend to average around $1.82 per pack. Washington D.C. is on the higher end of the tax spectrum at $4.50 per pack, whereas Missouri is only $0.17 per pack (https://nnw.fm/D3WnT).

TAAT Lifestyle & Wellness estimates that, if one pack of TAAT Beyond Tobacco was sold at 20% of all United States tobacco points of sale, the product would capture 0.25% of the market, the equivalent of approximately 2.7 million cartons of cigarettes per year.

Management Team

Setti Coscarella is the Chief Executive Officer of TAAT Lifestyle & Wellness Ltd. He is experienced in investment banking, private equity and entrepreneurship. In 2017, Mr. Coscarella was the lead strategist for Reduced-Risk Products at Philip Morris International. While there, he worked with thousands of smokers to better understand how to position smoking alternatives, developing programs that could help smokers convert to reduced-risk products. Mr. Coscarella holds an MBA from the Schulich School of Business, specializing in finance, marketing and corporate strategy. He also has a Bachelor of Science in mathematics and physics from the University of Toronto.

Tim Corkum is the company’s Chief Revenue Officer. He has a lengthy history in the tobacco industry, having served 21 years at Philip Morris International. Mr. Corkum has experience leading the international commercialization of combustible cigarettes and working on reduced-risk product offerings. During his 21-year tenure, he held senior positions in business development, sales strategy, key account management and corporate affairs. He holds a BA from Carleton University with a concentration in law.

Joe Deighan is Founder of TAAT Lifestyle & Wellness and oversees research and development. He is the founder of vape liquid ‘JJuice’, created in 2012. JJuice was distributed across all of the United States and in 26 other countries, alongside the private label production that was done for other brands. Mr. Deighan sold JJuice in a cash deal that was valued at over $800,000 in 2017. He currently handles all R&D and production for Beyond Tobacco, knowing the product better than anyone else in the company.

TAAT Lifestyle & Wellness Ltd. (TOBAF), closed Wednesday's trading session at $3.176, off by 0.125786%, on 89,408 volume with 243 trades. The average volume for the last 3 months is 95,240 and the stock's 52-week low/high is $0.620000004/$4.73999977.

Recent News

ISW Holdings Inc. (OTC: ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings Inc. (OTC: ISWH).

ISW Holdings (OTC: ISWH) (transitioning to “BlockQuarry,” pending name change), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, today announced the completion of an asset purchase agreement with Minerset LLC, a Delaware limited liability company. The agreement provides for the purchase by ISW Holdings of 400 state-of-the-art cryptocurrency miners. “As we have discussed in our recent communications, we are actively engaged in expansion in both our hosting and mining segments,” said Alonzo Pierce, president and chairman of ISW Holdings. “This asset purchase agreement with Minerset represents a material broadening of our in-house mining capacity and will enable us to drive further top-line growth in the second half of 2021 as we ramp up toward the sizable jump lined up for next year, thanks to our recent partnership deal with Bitmain.” To view the full press release, visit https://ibn.fm/jXxLw

ISW Holdings Inc. (OTC: ISWH), through its in-house initiatives and strategic partnerships, has invested in growing operations targeting the telehealth and cryptocurrency mining industries.

The company specializes in strategic brand development and early growth facilitation. Management maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

Mission

The company’s core mission is to enhance these sectors by implementing innovative services and products that are ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, thereby ensuring success in their chosen industries.

Cryptocurrency Mining

The start of 2021 saw a massive resurgence in interest surrounding bitcoin and cryptocurrency mining. In mid-February, bitcoin prices hit an all-time high of greater than $57,000, and heightened demand for cryptocurrency mining power has played a key role in exacerbating a global shortage of semiconductors and computer components.

With a foothold in the cryptocurrency mining space, ISW Holdings has placed significant focus on expanding its position and capitalizing on this momentum. Recent highlights include:

  • February 9, 2021: The company announced that its revolutionary Pod5 Cryptocurrency Mining Pod will be powered up into full operational launch at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania on February 12, 2021.
  • February 11, 2021: The company announced that it is in negotiations to purchase a large number of miners (between 300 and 900) in preparation for its coming Phase 3 expansion in mining volume.
  • February 23, 2021: The company announced its entry into a comprehensive Hosting and Maintenance Agreement prior to going online with its new ASIC s17 miners.
  • March 2, 2021: The company announced that it has successfully tripled its active cryptocurrency mining fleet with the addition of two new POD5IVE datacenters.

“As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in bitcoin prices,” Alonzo Pierce, President and Chairman of ISW Holdings, stated in a news release. “It currently costs about $11K in computing power to mine a single bitcoin. Bitcoin is pricing at over five times that level, making this is an exceptional ROI opportunity, and our responsibility to our shareholders is clear: continue to invest, expand and execute.”

Business Innovations

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. Some of the company’s current holdings and partnerships include:

  • Bit5ive LLC: ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.
  • Proceso LLC: ISW Holdings has partnered with Proceso LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining.
  • PHH Health: The company’s home health division answers the growing need for home care services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care.
  • Volum: The company’s logistics and supply chain management division is designed with the core goal of increasing supply chain efficiency, which is recognized as one of the key aspects of successfully growing any business.

Market Opportunity

ISW Holdings’ recent activity in the cryptocurrency mining sector has positioned it to capitalize on the forecast expansion of the cryptocurrency market in the coming years. According to data from MarketsandMarkets, the cryptocurrency space was valued at $1.03 billion in 2019 and is projected to reach $1.40 billion in 2024, achieving a CAGR of 6.18% during the forecast period.

The report suggests that major drivers for this growth will be the transparency of the underlying blockchain technology, the high volume of remittances in developing countries, the high cost of international remittance, expected fluctuations in monetary regulations and sustained investment in the cryptocurrency space by venture capital firms.

Management Team

Terry Williams is the Chief Executive Officer and Director of ISW Holdings. Mr. Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, he amassed considerable corporate experience at UPS (NYSE: UPS), where he took several logistical roles, managing more than 2,000 employees and a budget of more than $10 billion. Mr. Williams also serves as president of Airware Transportation and Logistics and Chief Financial Officer of AVI Insurance Caribbean. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce is the company’s President and Chairman. He brings a wealth of business development and wealth management experience to the ISW team, having spent the past 20 years building recognizable brands in multiple industry sectors. Mr. Pierce has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown is Secretary, Treasurer and Director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Ms. Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings Inc. (ISWH), closed Wednesday's trading session at $0.6948, off by 0.028777%, on 323,518 volume with 207 trades. The average volume for the last 3 months is 757,403 and the stock's 52-week low/high is $0.0152/$1.47000002.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading